Format
Sort by
Items per page

Send to

Choose Destination

Best matches for estrogens AND hormone replacement therapy AND postmenopause AND progestins:

Search results

Items: 1 to 20 of 834

1.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW.

JAMA. 2017 Dec 12;318(22):2224-2233. doi: 10.1001/jama.2017.18261.

PMID:
29234814
2.

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Gartlehner G, Patel SV, Feltner C, Weber RP, Long R, Mullican K, Boland E, Lux L, Viswanathan M.

JAMA. 2017 Dec 12;318(22):2234-2249. doi: 10.1001/jama.2017.16952. Review.

PMID:
29234813
3.

Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal women.

Piróg M, Jach R, Kacalska-Janssen O.

Acta Obstet Gynecol Scand. 2017 Dec;96(12):1438-1445. doi: 10.1111/aogs.13239. Epub 2017 Oct 31.

PMID:
28981954
4.

NAMS 3rd Utian Translational Science Symposium, October 2016, Orlando, Florida A conversation about hormone therapy: is there an appropriate dose, route, and duration of use?

The North American Menopause Society (NAMS).

Menopause. 2017 Nov;24(11):1221-1235. doi: 10.1097/GME.0000000000000986.

PMID:
28968302
5.

Effects of ultra-low-dose versus standard hormone therapy on fibrinolysis and thrombin generation in postmenopausal women.

Piróg M, Jach R, Undas A.

Eur J Obstet Gynecol Reprod Biol. 2017 Oct;217:77-82. doi: 10.1016/j.ejogrb.2017.08.023. Epub 2017 Aug 22.

PMID:
28865249
6.

Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).

Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM.

JAMA Intern Med. 2017 Oct 1;177(10):1471-1479. doi: 10.1001/jamainternmed.2017.3877.

7.

Clinical Pearls in women's health.

Faubion SS, Litin SC, Bundrick JB.

Dis Mon. 2017 Jun;63(6):149-157. doi: 10.1016/j.disamonth.2017.03.009. No abstract available.

PMID:
28651691
8.

The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.

Anagnostis P, Galanis P, Chatzistergiou V, Stevenson JC, Godsland IF, Lambrinoudaki I, Theodorou M, Goulis DG.

Maturitas. 2017 May;99:27-36. doi: 10.1016/j.maturitas.2017.02.009. Epub 2017 Feb 16. Review.

9.

Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.

Renoux C, Dell'Aniello S, Brenner B, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 May;26(5):554-560. doi: 10.1002/pds.4197. Epub 2017 Mar 22.

PMID:
28326633
10.

Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study.

Imtiaz B, Taipale H, Tanskanen A, Tiihonen M, Kivipelto M, Heikkinen AM, Tiihonen J, Soininen H, Hartikainen S, Tolppanen AM.

Maturitas. 2017 Apr;98:7-13. doi: 10.1016/j.maturitas.2017.01.002. Epub 2017 Jan 9.

PMID:
28274328
11.

Long-term hormone therapy for perimenopausal and postmenopausal women.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J.

Cochrane Database Syst Rev. 2017 Jan 17;1:CD004143. doi: 10.1002/14651858.CD004143.pub5. Review.

PMID:
28093732
12.

Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.

Vitale C, Mammi C, Gambacciani M, Russo N, Spoletini I, Fini M, Volterrani M, Rosano GMC.

Int J Cardiol. 2017 Jan 15;227:217-221. doi: 10.1016/j.ijcard.2016.11.149. Epub 2016 Nov 9.

PMID:
27843051
13.

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.

Santoro N, Allshouse A, Neal-Perry G, Pal L, Lobo RA, Naftolin F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Dunn M, Gleason CE, Hodis HN, Isaac B, Magnani M, Manson JE, Miller VM, Taylor HS, Wharton W, Wolff E, Zepeda V, Harman SM.

Menopause. 2017 Mar;24(3):238-246. doi: 10.1097/GME.0000000000000756.

14.

Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study.

Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Menopause. 2016 Nov;23(11):1199-1203.

PMID:
27465718
15.

Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease.

Osmanovic-Barilar J, Salkovic-Petrisi M.

Drugs Aging. 2016 Nov;33(11):787-808. Review.

PMID:
27709466
16.

Hormone replacement therapy and the risk of endometrial cancer: A systematic review.

Sjögren LL, Mørch LS, Løkkegaard E.

Maturitas. 2016 Sep;91:25-35. doi: 10.1016/j.maturitas.2016.05.013. Epub 2016 Jun 1. Review.

PMID:
27451318
17.

Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis.

Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ.

Neurology. 2016 Aug 16;87(7):699-708. doi: 10.1212/WNL.0000000000002980. Epub 2016 Jul 15.

18.

Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.

Canonico M, Carcaillon L, Plu-Bureau G, Oger E, Singh-Manoux A, Tubert-Bitter P, Elbaz A, Scarabin PY.

Stroke. 2016 Jul;47(7):1734-41. doi: 10.1161/STROKEAHA.116.013052. Epub 2016 Jun 2.

19.

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.

Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP; ELITE Research Group.

N Engl J Med. 2016 Mar 31;374(13):1221-31. doi: 10.1056/NEJMoa1505241.

20.

Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.

Bergendal A, Kieler H, Sundström A, Hirschberg AL, Kocoska-Maras L.

Menopause. 2016 Jun;23(6):593-9. doi: 10.1097/GME.0000000000000611.

PMID:
27023862

Supplemental Content

Loading ...
Support Center